Grabar Law probes Bloom Energy, Cogent, Insulet, Primoris for fiduciary breaches
Grabar Law Office is investigating fiduciary duty breaches at Bloom Energy, Cogent Communications, Insulet, and Primoris Services. Allegations include misleading statements on Chinese scandium sourcing, inflated optical wavelength backlogs, defective manufacturing controls, and underestimated project costs. Shareholders holding stock before specified dates are urged to contact the firm for potential governance actions or class action participation.

*this image is generated using AI for illustrative purposes only.
Grabar Law Office is investigating claims on behalf of shareholders of Bloom Energy Corporation (NYSE: BE), Cogent Communications Holdings, Inc. (NASDAQ: CCOI), Insulet Corporation (NASDAQ: PODD), and Primoris Services Corporation (NYSE: PRIM). The Philadelphia-based law firm alleges that certain officers and directors at each company breached their fiduciary duties.
Bloom Energy Corporation (NYSE: BE)
The investigation concerns allegations that Bloom Energy made false or misleading statements regarding its supply chain reliance on China. According to a federal securities class action lawsuit, the company failed to disclose that it obtained scandium through intermediaries sourcing the metal from China. This allegedly understated the extent of its reliance on Chinese scandium, rendering positive statements about its business prospects materially misleading.
A July 8, 2026 report by Hunterbrook Media titled "Bloom’s Big Lie" alleged that global trade data and satellite imagery traced four China-linked routes into Bloom’s supply chain. These included scandium oxide shipped directly to its Delaware plant and scandium-bearing ceramics flowing through intermediaries in Thailand, Japan, and South Korea. On this news, Bloom Energy stock fell nearly 6%.
Shareholders who purchased shares prior to February 27, 2025, and still hold them may seek corporate reforms and return of funds through a shareholder governance action.
Cogent Communications Holdings, Inc. (NASDAQ: CCOI)
Cogent Communications faces allegations that it misrepresented customer demand and the nature of its optical wavelength "backlog." A securities fraud class action complaint alleges that the vast majority of purported orders were unlikely to result in paid orders, with many customers unable or unwilling to accept delivery. Consequently, defendants allegedly misrepresented that Cogent was on track to achieve revenue and margin targets.
Additionally, the complaint alleges Cogent lacked the financial capacity to maintain its dividend policy and failed to disclose risks related to high-risk stock pledging activities by defendant David Schaeffer. Shareholders who purchased shares before February 29, 2024, and still hold them are encouraged to participate.
Insulet Corporation (NASDAQ: PODD)
Insulet Corporation is under investigation for alleged defective manufacturing controls and procedures. A federal securities fraud class action complaint states that these defects created a foreseeable risk of products violating safety regulations or posing injury risks. Public statements regarding these controls were allegedly materially false.
Insulet disclosed a voluntary Medical Device Correction for specific lots of Omnipod 5 Pods on March 12, 2026, citing a manufacturing issue identified through product monitoring. A second correction was initiated on May 26, 2026, for specific lots of Omnipod 5, Omnipod Dash, and Omnipod Eros Pods due to a manufacturing issue that could result in insulin under-delivery. Shareholders who purchased shares prior to February 21, 2025, and still hold them may seek corporate reforms.
Primoris Services Corporation (NYSE: PRIM)
Primoris Services Corporation faces allegations that its cost estimation and project oversight processes were deficient. A securities fraud class action complaint alleges the company systematically underestimated costs and risks for significant fixed-price renewable energy projects, which experienced material cost overruns and schedule delays. Statements regarding financial performance and guidance allegedly lacked a reasonable basis.
Shareholders who purchased shares before August 5, 2025, and still hold them may seek corporate reforms through a governance action. Those who purchased between August 5, 2025, and June 22, 2026, can participate in the class action.
What the Numbers Show
The investigations highlight significant divergence between disclosed operational metrics and alleged underlying realities across diverse sectors. In technology hardware (Bloom Energy), the focus is on supply chain opacity versus public statements. In telecommunications (Cogent), the allegation centers on the quality of order backlog versus actual payable revenue. For medical devices (Insulet), the disconnect lies between stated manufacturing controls and subsequent voluntary corrections. In infrastructure (Primoris), the issue is the reliability of cost estimates versus actual project execution outcomes. Each case involves a claim that management’s public disclosures did not reflect material adverse facts known internally.
How might the allegations regarding Bloom Energy's supply chain opacity impact its eligibility for federal clean energy tax credits that require domestic sourcing?
Could Cogent Communications' alleged misrepresentation of its order backlog trigger a broader re-evaluation of revenue recognition practices across the telecommunications infrastructure sector?
What long-term reputational damage or regulatory scrutiny could Insulet Corporation face if the manufacturing defects in its Omnipod devices are found to be systemic rather than isolated incidents?

































